The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04576455
Brief Title: A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

First Submitted : September 30, 2020
First Submitted that Met QC Criteria : September 30, 2020
First Posted : October 6, 2020

Results First Submitted : February 13, 2023
Results First Submitted that Met QC Criteria : February 13, 2023
Results First Posted : March 10, 2023

Last Update Submitted that Met QC Criteria : February 26, 2024
Last Update Posted : February 28, 2024